Standout Papers

Effect of Vericiguat vs Placebo on Quality of Life in ... 2015 2026 2018 2022 735
  1. Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction (2020)
    Paul W. Armstrong, Carolyn S.P. Lam et al. JAMA
  2. Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction (2020)
    Paul W. Armstrong, Burkert Pieske et al. New England Journal of Medicine
  3. Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction (2015)
    Mihai Gheorghiade, Stephen J. Greene et al. JAMA

Immediate Impact

11 from Science/Nature 92 standout
Sub-graph 1 of 17

Citing Papers

Ultrasound-Based Micro-/Nanosystems for Biomedical Applications
2024 Standout
Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity
2024 Standout
23 intermediate papers

Works of Lothar Roessig being referenced

Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction
2020 Standout
Patient-Reported Outcomes in the Soluble Guanylate Cyclase Stimulator in Heart Failure Patients with Preserved Ejection Fraction (SOCRATES-PRESERVED) Study
2017
and 10 more

Author Peers

Author Last Decade Papers Cites
Lothar Roessig 2907 697 81 612 63 3.5k
Isaac Kobrin 2293 604 28 319 96 2.8k
Margaret F. Prescott 3061 638 48 775 110 4.2k
Manuel Worcel 1654 269 89 544 86 3.0k
David Collier 2026 477 73 525 80 3.5k
Armin Scherhag 2174 312 99 377 60 4.2k
Hollis D. Kleinert 2317 452 10 439 60 3.4k
Anne L. Taylor 2026 338 109 367 67 3.5k
Jasper Tromp 2688 483 92 694 140 3.6k
Masanori Fujii 1950 307 30 549 63 2.6k
B M Brenner 1804 1075 8 847 67 5.6k

All Works

Loading papers...

Rankless by CCL
2026